These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23341859)

  • 1. The immune response to papillomavirus during infection persistence and regression.
    Hibma MH
    Open Virol J; 2012; 6():241-8. PubMed ID: 23341859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors in human papillomavirus infection.
    Zhou Q; Zhu K; Cheng H
    Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
    J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.
    Raikhy G; Woodby BL; Scott ML; Shin G; Myers JE; Scott RS; Bodily JM
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of host immune defenses by human papillomavirus.
    Westrich JA; Warren CJ; Pyeon D
    Virus Res; 2017 Mar; 231():21-33. PubMed ID: 27890631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host responses to infection with human papillomavirus.
    Stanley MA; Sterling JC
    Curr Probl Dermatol; 2014; 45():58-74. PubMed ID: 24643178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection.
    Senba M; Mori N
    Oncol Rev; 2012 Oct; 6(2):e17. PubMed ID: 25992215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to human papilloma viruses.
    Stanley MA
    Indian J Med Res; 2009 Sep; 130(3):266-76. PubMed ID: 19901436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.
    Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial cell responses to infection with human papillomavirus.
    Stanley MA
    Clin Microbiol Rev; 2012 Apr; 25(2):215-22. PubMed ID: 22491770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines and immunization against human papillomavirus.
    Christensen ND; Budgeon LR
    Curr Probl Dermatol; 2014; 45():252-64. PubMed ID: 24643192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between toll-like receptor expression and human papillomavirus type 16 persistence.
    Daud II; Scott ME; Ma Y; Shiboski S; Farhat S; Moscicki AB
    Int J Cancer; 2011 Feb; 128(4):879-86. PubMed ID: 20473890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermotropism of T cells correlates with intercellular adhesion molecule (ICAM1) expression in human papillomavirus (HPV)-induced lesions.
    Viac J; Chardonnet Y; Euvrard S; Schmitt D
    J Pathol; 1992 Nov; 168(3):301-6. PubMed ID: 1361527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes.
    Dupuy C; Buzoni-Gatel D; Touzé A; Bout D; Coursaget P
    J Virol; 1999 Nov; 73(11):9063-71. PubMed ID: 10516012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
    Sasagawa T; Takagi H; Makinoda S
    J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV modulation of host immune responses.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J
    SADJ; 2010 Jul; 65(6):266-8. PubMed ID: 20879650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy.
    Smola S; Trimble C; Stern PL
    Ther Adv Vaccines; 2017 Jun; 5(3):69-82. PubMed ID: 28794879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Interferon Kappa in Human Papillomavirus 16 Infection by Transforming Growth Factor Beta-Induced Promoter Demethylation.
    Woodby BL; Songock WK; Scott ML; Raikhy G; Bodily JM
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins.
    Lo Cigno I; Calati F; Albertini S; Gariglio M
    Pathogens; 2020 Apr; 9(4):. PubMed ID: 32316236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.
    Ho GY; Burk RD; Klein S; Kadish AS; Chang CJ; Palan P; Basu J; Tachezy R; Lewis R; Romney S
    J Natl Cancer Inst; 1995 Sep; 87(18):1365-71. PubMed ID: 7658497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.